AF
IMVT icon

Allworth Financial’s Immunovant IMVT Stock Holding History

Allworth Financial’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.5K Buy
506
+3
+0.6% +$91 ﹤0.01% 3223
2026
Q1 		$12.5K Buy
503
+26
+5% +$673 ﹤0.01% 3350
2025
Q4 		$12.1K Sell
477
-52
-10% -$1.16K ﹤0.01% 3140
2025
Q3 		$8.53K Buy
529
+276
+109% +$4.47K ﹤0.01% 3240
2025
Q2 		$4.05K Buy
253
+209
+475% +$3.16K ﹤0.01% 3378
2025
Q1 		$664 Buy
44
+35
+389% +$732 ﹤0.01% 3606
2024
Q4 		$210 Buy
9
+2
+29% +$57 ﹤0.01% 3778
2024
Q3 		$200 Hold
7
– – ﹤0.01% 3596
2024
Q2 		$196 Buy
+7
New +$199 ﹤0.01% 3552

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Allworth Financial's IMVT Position: Q2 2026 in Review

Allworth Financial increased its Immunovant (IMVT) stake by 0.6% in Q2 2026, buying an estimated $91 and bringing the position to 506 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3223.

Allworth Financial first reported a position in IMVT in Q2 2024 and has held it in 9 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Allworth Financial held 506 shares of Immunovant worth $19.5K as of Q2 2026.
  • Allworth Financial bought 3 Immunovant shares in Q2 2026, an estimated $91.
  • Immunovant made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3223 holding.
  • Allworth Financial first reported a position in Immunovant in Q2 2024 and has held it in 9 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.